Found 3381 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients
PHASE2Open label multicentric randomized phase II trial, using high throughput ge...
Location
Centre Hospitalier Henri Duffau
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy
PHASE2The trial is designed as a multi-center, open label Phase 2 trial that inve...
Location
3203; Antwerp University Hospital; Department of Medical Oncology
A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors
PHASE1The primary objective is to determine the safety and tolerability of SH3809...
Location
Shanghai Chest Hospital
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
N/ALung cancer (LC) is the tumor responsible for the highest mortality worldwi...
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer
PHASE2The objective of this study is to assess the efficacy, safety of MRG003 as ...
Location
Cancer Hospital Chinese Academy of Medical Sciences
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
PHASE2Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Location
Multiple Locations
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
N/ATo estimate parameters related to clinical outcomes in a real-world seeting...
Status
Active Not Recruiting
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
PHASE1The goal of this randomized clinical trial is to learn if topical treatment...
Location
Genesis Cancer and Blood Institute